title: Analysis of characteristics of paratyphoid A in 157 Chinese inpatients between 1998 and 2009.
abstract: The objectives of this study were to understand the epidemic rules, clinical characteristics, and drug resistance of paratyphoid A by analyzing 157 cases in the Wenzhou area of China during a 12-year period. The subjects included in the present study were patients with paratyphoid A who were admitted to the First Affiliated Hospital of Wenzhou Medical College (Wenzhou, ZJ, China) between 1998 and 2009. The disease mainly occurred in persons aged 20 to 50 years. The peak incidence was between 2001 and 2003 (n = 85). Paratyphoid A was more likely to occur in winter and spring in this area. In many cases (33.8%), the condition was complicated by underlying diseases. The length of hospital stay was relatively long, averaging 17.68 days. The white blood cell (WBC) count was 2-8 × 10(9)/L in 88.5% of cases. Eosinophils disappeared in 51.7% of cases. The erythrocyte sedimentation rate (ESR) was not significant and lower than 60 mm/h in 88.5% of cases. Alanine aminotransferase (ALT) was ≤3-fold greater than the normal value in 84.3% of cases. The Widal test was positive in only 7.7% of our cases. The sensitivity of many antibiotics was over 90%. Paratyphoid A in the Wenzhou area has unique epidemic rules, clinical characteristics, and drug resistance. The results of our retrospective analysis are instructive for the early diagnosis and rational treatment of paratyphoid A.
authors.affiliation: Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China. tjyufujun@163.com
authors.forename: F
authors.initials: F
authors.lastname: Yu
authors.forename: S
authors.initials: S
authors.lastname: Fan
authors.forename: X
authors.initials: X
authors.lastname: Fan
authors.forename: P
authors.initials: P
authors.lastname: Dong
authors.forename: X
authors.initials: X
authors.lastname: Wang
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: J
authors.initials: J
authors.lastname: Li
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002681:China / Q000453:epidemiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D007902:Length of Stay; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010284:Paratyphoid Fever / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology* / Q000473:pathology; D012189:Retrospective Studies; D012482:Salmonella paratyphi A / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents
references.citation: Indian J Pediatr. 2008 May;75(5):509-10
references.pmid: 18537014
references.citation: Trop Doct. 2010 Jul;40(3):160-2
references.pmid: 20478986
references.citation: Hum Vaccin. 2009 Jun;5(6):420-4
references.pmid: 19276655
references.citation: Diagn Microbiol Infect Dis. 2009 Aug;64(4):422-6
references.pmid: 19631095
references.citation: Indian Pediatr. 2007 Dec;44(12):939
references.pmid: 18175854
references.citation: Bull World Health Organ. 2004 May;82(5):346-53
references.pmid: 15298225
references.citation: JAMA. 2009 Aug 26;302(8):859-65
references.pmid: 19706859
references.citation: J Clin Microbiol. 2001 Mar;39(3):1002-7
references.pmid: 11230418
references.citation: Heart Lung. 2004 Nov-Dec;33(6):414-6
references.pmid: 15597296
references.citation: Indian J Med Microbiol. 2010 Jan-Mar;28(1):51-3
references.pmid: 20061765
references.citation: Scand J Infect Dis. 2005;37(4):309-10
references.pmid: 15804669
references.citation: Med Mal Infect. 2008 Dec;38(12):667-70
references.pmid: 18951744
references.citation: Arch Pathol Lab Med. 2006 Jun;130(6):767-78
references.pmid: 16740026
references.citation: Trop Doct. 2009 Oct;39(4):223-4
references.pmid: 19762576
references.citation: BMC Public Health. 2009 Dec 20;9:476
references.pmid: 20021691
references.citation: Emerg Infect Dis. 2005 Nov;11(11):1764-6
references.pmid: 16318734
references.citation: Int J Antimicrob Agents. 2010 Aug;36(2):155-8
references.pmid: 20478696
references.citation: J Travel Med. 2008 Sep-Oct;15(5):366-8
references.pmid: 19006514
references.citation: J Infect Dev Ctries. 2008 Dec 01;2(6):475-8
references.pmid: 19745527
references.citation: Indian J Med Sci. 2004 Apr;58(4):161-2
references.pmid: 15122052
references.citation: Trans R Soc Trop Med Hyg. 2007 Oct;101(10):1032-8
references.pmid: 17673269
references.citation: Nihon Rinsho. 2005 Jul;63 Suppl 7:142-5
references.pmid: 16111211
references.citation: BMC Public Health. 2009 Apr 27;9:115
references.pmid: 19397806
references.citation: Diagn Microbiol Infect Dis. 2010 Feb;66(2):207-9
references.pmid: 19800753
references.citation: Indian J Pathol Microbiol. 2009 Oct-Dec;52(4):505-8
references.pmid: 19805957